Epsium Enterprise Appoints New CFO with Extensive SEC Reporting Experience Following Resignation
Summary
Epsium Enterprise Ltd announced the resignation of its Chief Financial Officer, Mr. Ming Yin Gordan Au Yeung, and the immediate appointment of Mr. Ching Wan Wong as the new CFO, effective May 1, 2026.
Key Events
-
Chief Financial Officer Resignation
Mr. Ming Yin Gordan Au Yeung resigned from his position as Chief Financial Officer, effective April 30, 2026, citing personal reasons and no disagreements with management.
-
New CFO Appointment
The Board appointed Mr. Ching Wan Wong as the new Chief Financial Officer, effective May 1, 2026.
-
New CFO's Extensive Experience
Mr. Wong brings over 25 years of experience in finance, accounting, and regulatory compliance, with significant expertise in U.S. SEC reporting and Hong Kong listing compliance, including previous CFO roles at Intelligent Living Application Group Inc. and Fuqi International, Inc.
-
Compensation Details
Mr. Wong will receive an annual compensation of USD 120,000 (USD 10,000 per month) and has entered into an indemnification agreement with the company.
Analysis
This executive change follows closely on the heels of the company's recent 20-F filing on April 29, 2026, which reported a significant revenue drop and net loss for fiscal year 2025. While the outgoing CFO's resignation is attributed to personal reasons, the timing suggests a potential response to the company's financial performance. The appointment of Ching Wan Wong, who possesses over 25 years of experience in finance, accounting, and regulatory compliance, particularly with U.S. SEC reporting and Hong Kong listing compliance, is a positive development. His background, including prior CFO roles at other public companies, is crucial for Epsium Enterprise Ltd, especially given its recent financial challenges and the need for robust financial oversight and compliance.
At the time of this filing, EPSM was trading at $1.42 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $19.1M. The 52-week trading range was $1.04 to $155.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.